Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for parkinson's disease

Pigment Cell and Melanoma Research

Volumn 22, Issue 6, 2009, Pages 851-853

  Charles, Julie ^a,b   Templier, Isabelle ^a   Leroux, Dominique ^a,b   Salameire, Dimitri ^a,b   Robert, Caroline ^c   Lantuejoul, Sylvie ^a,b   Leccia, Marie Therese ^a,b  

^a HÔPITAL MICHALLON   (France)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; LEVODOPA; MELANOCORTIN 1 RECEPTOR;

ADULT; CANCER SUSCEPTIBILITY; CASE REPORT; DNA REPAIR; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; NEVUS; PARKINSON DISEASE; PRIMARY TUMOR; SEQUENCE ANALYSIS; SKIN EXAMINATION;

DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEVODOPA; MALE; MELANOMA; MIDDLE AGED; PARKINSON DISEASE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 70350122933     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00624.x     Document Type: Letter

References (5)

1. Goldstein, A.M., Chan, M., Harland, M. et al. (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J. Med. Genet. 44, 99 106.
2. Govindarajan, B., Sligh, J.E., Vincent, B.J. et al. (2007). Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J. Clin. Invest. 117, 719 729.
3. Kannengiesser, C., Dalle, S., Leccia, M.T. et al. (2007). New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment. Genes Chromosomes Cancer 46, 751 760.
4. Olsen, J.H., Friis, S. Frederiksen, K. (2006). Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 17, 582 587.
5. Zanetti, R., Loria, D. Rosso, S. (2006). Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma Res. 16, 201 206.